Call Now Open
Oxford-Harrington Rare Disease Scholar Award
“The experts associated with Harrington are extremely valuable because of their market awareness and knowledge of the commercial aspects required for successfully advancing a new molecule to the clinic. As an academic scientist, that part of drug development is totally unknown to me."
TRAVIS DUNCKLEY, PhD
Assistant Research Professor
ASU-Banner Neurodegenerative Disease Research Center
Arizona State University
2016 ADDF-Harrington Scholar
“The compound that we discovered is able to increase brain activity to help restore the ability for that patient to learn and remember. I don't think that would have happened without the contribution of Harrington.”
JERRI ROOK, PhD
Assistant Professor, Department of Pharmacology
Vanderbilt University School of Medicine
2015 ADDF-Harrington Scholar
"After crawling for 10 years, Harrington is helping move this project at the speed of light!"
EUGENIA TRUSHINA, PhD
Professor of Neurology
Associate Professor of Pharmacology
2019 ADDF-Harrington Scholar
“The industry perspective we have gained from our Harrington advisory team is tremendously valuable.”
CHRISTIANE WRANN, DVM, PhD
Associate Professor in Medicine
Cardiovascular Research Center and McCance Center for Brain Health
Massachusetts General Hospital and Harvard Medical School
2021 ADDF-Harrington Scholar
The Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute provide funding and drug development support of research efforts that aim to treat or prevent Alzheimer’s disease, related dementias and cognitive-decline associated with aging. Each year up to two ADDF-Harrington Scholars are chosen. The award includes:
Join our emailing list to become a part of our community and receive periodic communications about grant funding opportunities, as well as news and updates.
Late submissions will not be accepted for any reason, other than issues with the Harrington Discovery Institute’s submission system. Proposals received after the deadline will not be reviewed.
The ADDF-Harrington Scholar award selection committee seeks breakthrough discoveries that demonstrate innovation, creativity and potential for clinical impact, including: